Float Short %

7.91

Margin Of Safety %

Put/Call OI Ratio

0.51

EPS Next Q Diff

-0.19

EPS Last/This Y

-0.44

EPS This/Next Y

0.18

Price

16.79

Target Price

20.83

Analyst Recom

2.43

Performance Q

-0.53

Relative Volume

0.94

Beta

2.13

Ticker: INMD

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2024-12-19	INMD	17.17	0.53	3.44	54909
2024-12-20	INMD	17.07	0.54	2.19	55448
2024-12-23	INMD	16.96	0.55	0.82	51250
2024-12-24	INMD	17.06	0.53	6.32	51305
2024-12-26	INMD	17.29	0.55	1.44	52165
2024-12-27	INMD	17.01	0.55	0.45	52212
2024-12-30	INMD	16.62	0.55	0.72	52375
2024-12-31	INMD	16.71	0.55	0.38	52809
2025-01-02	INMD	16.98	0.55	0.70	53042
2025-01-03	INMD	17.02	0.55	2.40	53301
2025-01-06	INMD	17.12	0.54	1.14	53554
2025-01-07	INMD	17.4	0.54	0.20	53826
2025-01-08	INMD	16	0.54	0.97	54178
2025-01-09	INMD	16.01	0.54	1.09	54178
2025-01-10	INMD	15.9	0.53	0.22	55713
2025-01-13	INMD	15.98	0.52	1.04	56006
2025-01-14	INMD	16.08	0.51	1.74	56688
2025-01-15	INMD	16.52	0.49	1.67	56375
2025-01-16	INMD	16.58	0.51	0.33	57749
2025-01-17	INMD	16.79	0.51	0.61	58289
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2024-12-19	INMD	17.17	-17.4	18.4	1.93
2024-12-20	INMD	17.08	-17.4	15.9	1.93
2024-12-23	INMD	16.95	-17.4	15.7	1.93
2024-12-24	INMD	17.06	-17.4	20.2	1.93
2024-12-26	INMD	17.30	-17.4	22.5	1.93
2024-12-27	INMD	17.02	-17.4	13.0	1.93
2024-12-30	INMD	16.63	-17.4	10.6	1.93
2024-12-31	INMD	16.71	-17.4	19.8	1.93
2025-01-02	INMD	16.98	-17.4	23.6	1.93
2025-01-03	INMD	17.02	-17.4	19.4	1.93
2025-01-06	INMD	17.12	-17.4	20.1	1.93
2025-01-07	INMD	17.42	-17.4	23.7	1.93
2025-01-08	INMD	16.01	-17.4	-7.2	1.93
2025-01-09	INMD	16.01	-17.4	18.0	1.93
2025-01-10	INMD	15.90	-17.4	15.5	1.93
2025-01-13	INMD	15.97	-17.4	19.7	1.93
2025-01-14	INMD	16.08	-17.4	20.4	1.93
2025-01-15	INMD	16.54	-17.4	28.2	1.93
2025-01-16	INMD	16.57	-17.4	18.8	1.93
2025-01-17	INMD	16.79	-17.4	22.5	1.93
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2024-12-19	INMD	0.00	-12.34	7.90
2024-12-20	INMD	0.00	-12.34	7.90
2024-12-23	INMD	0.00	-12.59	7.90
2024-12-24	INMD	0.00	-12.59	7.90
2024-12-26	INMD	0.00	-12.59	8.02
2024-12-27	INMD	0.00	-12.59	8.02
2024-12-30	INMD	0.00	-11.62	8.02
2024-12-31	INMD	0.00	-11.62	8.02
2025-01-02	INMD	0.00	-11.62	8.02
2025-01-03	INMD	0.00	-11.62	8.02
2025-01-06	INMD	0.00	-11.79	8.02
2025-01-07	INMD	0.00	-11.79	8.02
2025-01-08	INMD	0.00	-11.79	8.02
2025-01-09	INMD	0.00	-11.79	8.02
2025-01-10	INMD	0.00	-11.79	8.02
2025-01-13	INMD	0.00	-12.31	7.91
2025-01-14	INMD	0.00	-12.31	7.91
2025-01-15	INMD	0.00	-12.31	7.91
2025-01-16	INMD	0.00	-12.31	7.91
2025-01-17	INMD	0.00	-12.31	7.91
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.65

Avg. EPS Est. Current Quarter

0.59

Avg. EPS Est. Next Quarter

0.46

Insider Transactions

Institutional Transactions

-12.31

Beta

2.13

Average Sales Estimate Current Quarter

117

Average Sales Estimate Next Quarter

Fair Value

21.65

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

83.1

Max Drawdown 5-Year %

-84.8

Target Price

20.83

P/E

9.08

Forward P/E

8.48

PEG

P/S

3.35

P/B

1.93

P/Free Cash Flow

9.02

EPS

1.85

Average EPS Est. Cur. Y

1.93

EPS Next Y. (Est.)

2.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

36.26

Relative Volume

0.94

Return on Equity vs Sector %

1.8

Return on Equity vs Industry %

8.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

22.5

InMode Ltd.

Sector: Healthcare

Industry: Medical Devices

Employees: 581

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

stock quote shares INMD – InMode Ltd. Stock Price stock today

news today INMD – InMode Ltd. stock forecast ,stock prediction 2023 2024 2025

marketwatch INMD – InMode Ltd. yahoo finance google finance

stock history INMD – InMode Ltd. invest stock market

stock prices INMD premarket after hours

ticker INMD fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: INMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y